Federal Anti-Virus Strategy Must Encourage Broader Innovation To Expand Treatment Options

Public health officials should apply the lessons learned during the pandemic to accelerate production of anti-viral tools needed by the most vulnerable Americans.

Related Keywords

United States ,White House ,District Of Columbia ,Americans ,American ,Robert Califf ,Lori Trahan ,Drug Administration ,Emergency Use Authorizations ,Representatives Dan Crenshaw ,Commissioner Califf ,Supplemental Biologics License , ,